Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients

Abstract Objectives The objectives of the study are to explore tolerability, acceptability and oncological outcomes for patients with high‐risk non‐muscle‐invasive bladder cancer (NMIBC) treated with hyperthermic intravesical chemotherapy (HIVEC) and mitomycin‐C (MMC) at our institution. Patients an...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Samantha Conroy, Karl Pang, Ibrahim Jubber, Syed A. Hussain, Derek J. Rosario, Marcus G. Cumberbatch, James W. F. Catto, Aidan P. Noon
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2023-05-01
Saila:	BJUI Compass
Gaiak:	acceptability high risk hyperthermic intravesical chemotherapy intravesical treatment mitomycin C non‐muscle‐invasive bladder cancer
Sarrera elektronikoa:	https://doi.org/10.1002/bco2.203
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!